Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
According to CMS billing guidance (Medicare Article A57755), the primary covered indications are pernicious anemia, documented cobalamin deficiency with laboratory evidence, and malabsorption syndromes that prevent adequate oral B12 absorption
Already have an account
Because NAD
This analysis gives researchers confidence in their data and supports reproducibility required for publications and peer review
AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection
US$ 25.47
US$ 26.75
US$ 23.79
US$ 29.02
US$ 23.79
US$ 27.02
US$ 29.52
US$ 27.53
US$ 25.09
US$ 21.11
US$ 23.43
US$ 27.11
